1. Home
  2. PLX vs SCM Comparison

PLX vs SCM Comparison

Compare PLX & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.90

Market Cap

207.1M

Sector

Health Care

ML Signal

SELL

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

SELL

Current Price

$6.16

Market Cap

211.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PLX
SCM
Founded
1993
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
207.1M
211.0M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
PLX
SCM
Price
$2.90
$6.16
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
★ $12.00
$9.63
AVG Volume (30 Days)
★ 990.1K
196.6K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
★ 15.92%
EPS Growth
N/A
★ N/A
EPS
0.31
★ 0.40
Revenue
★ $52,744,000.00
N/A
Revenue This Year
$64.22
N/A
Revenue Next Year
N/A
$4.20
P/E Ratio
★ $9.85
$15.70
Revenue Growth
N/A
★ N/A
52 Week Low
$1.65
$6.27
52 Week High
$3.19
$13.55

Technical Indicators

Market Signals
Indicator
PLX
SCM
Relative Strength Index (RSI) 56.51 26.48
Support Level $2.08 N/A
Resistance Level $3.19 $8.81
Average True Range (ATR) 0.20 0.28
MACD 0.03 -0.06
Stochastic Oscillator 71.74 2.27

Price Performance

Historical Comparison
PLX
SCM

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.

Share on Social Networks: